Malignant solid tumor
Conditions
Interventions
Control group:None
Sponsors
Department of Radiotherapy, the Second Affiliated Hospital, Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed as malignant tumor (solid tumor) by pathology or cytology; 2.Patients with moderate to severe fatigue (4-10 points); 3.Clear mind, can objectively cooperate with the doctor to complete the examination and evaluation; 4.ECoG score of physical condition was 0-3; 5.Expected survival >= 3 months; 6.Aged 18-75 years; 7.Voluntary participation, signing informed consent, good compliance and cooperation with follow-up.
Exclusion criteria
Exclusion criteria: 1.Patients with clinically significant liver dysfunction, i.e. glutamic oxaloacetic transaminase or alanine transaminase > 2.5 fold ULN, total serum bilirubin > 1.5 fold ULN; 2.Patients with clinically significant renal insufficiency, i.e. serum creatinine > 1.5 fold ULN; 3.Patients with severe heart disease, i.e. NYHA grade III-IV heart failure, unstable angina pectoris, myocardial infarction, underwent coronary artery reconstruction within 6 months before admission; 4.Patients with splenectomy or other serious hematopoietic system diseases; 5.Uncontrolled diabetes, hypertension (systolic blood pressure > 180mmhg and / or diastolic blood pressure > 120mmhg), uncontrollable infection, and severe peptic ulcer; 6.Mental patients without self-knowledge ability, those without legal capacity or limited legal capacity; 7.Patients who are pregnant, lactating or have the possibility of pregnancy and planned pregnancy; 8.Patients have participated in or are participating in other clinical studies in the past one month; 9.The researchers believe that there are any other unsuitable candidates. Determine other situations that may affect the clinical research and the interpretation of research results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACT-G scale;FACT-F scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nutritional status (body mass index, hemoglobin, serum albumin, prealbumin, etc.);Physical condition (ECOG score);Therapeutic safety; | — |
Countries
China
Contacts
Public ContactMa Hongbin
Department of Radiotherapy, the Second Affiliated Hospital, Xi'an Jiaotong University
Outcome results
None listed